KIR2DL1 and COVID-19: An increased frequency of KIR2DL1+HLA-C2+ combination, particularly without the activating counterpart KIR2DS1 or KIR2DS5 in mild COVID-19 cases than severe COVID-19 cases, suggests a protective role for KIR2DL1+HLA-C2+ against developing severe COVID-19.